Venrock PIPEs Chelsea Therapeutics
Venrock is leading an $18.2 million PIPE into drug company Chelsea Therapeutics International Ltd. (Nasdaq: CHTP). The deal includes 6.7 million shares of common stock being purchased at $2.72 per share, along with warrants to purchase another 2.3 million common shares. Leerink Swann and Needham & Co. served as placement agents.
1 March 2010•3 mins read
